Group 1 - Liu Pharmaceutical Group plans to repurchase shares worth between 100 million and 200 million yuan, with a maximum repurchase price of 25.70 yuan per share [1] - Dongshan Precision intends to invest up to 1 billion USD to build a high-end printed circuit board project to meet the long-term demand for high-end printed circuit boards in emerging scenarios such as AI [1] - Bomaike reported a net profit of 12.39 million yuan for the first half of the year, a year-on-year decline of 80.42% [2] Group 2 - Western Mining achieved a net profit of 1.869 billion yuan in the first half of the year, a year-on-year increase of 15% [2] - Fuliwang expects a net loss of approximately 17 million yuan for the first half of the year, a decrease of 137.12% compared to the same period last year [2] - Digital Certification anticipates a net loss of between 80 million and 96 million yuan for the first half of the year, compared to a loss of 29.25 million yuan in the same period last year [3] Group 3 - Shanghai Construction reported a net profit of 710 million yuan for the first half of the year, a year-on-year decrease of 14.04% [5] - Funneng Co. achieved a net profit of 1.337 billion yuan in the first half of the year, a year-on-year increase of 12.48% [6] - Tengda Construction's total contract amount for the first half of the year decreased by 17.55% year-on-year [7] Group 4 - Fudan Fuhua decided to terminate the public transfer of a 28% stake in a subsidiary due to the lack of a deposit from potential buyers [9] - Fulei Ant's subsidiary has decided to cease operations due to intense competition in the photovoltaic industry and ongoing losses [11] - Dongfang Ocean's subsidiary received a medical device registration certificate for a folic acid testing kit [14] Group 5 - Huayu Pharmaceutical's subsidiary received overseas listing approvals for several products [16] - Feima International received a performance commitment compensation of 437 million yuan from its controlling shareholder [16] - Guangshen Railway signed a cooperation agreement for the Guangzhou East Station renovation project with a total investment of approximately 16.66 billion yuan [16] Group 6 - Anhui Construction won the bid for the S68 Jingde to Jixi Expressway project with an estimated total investment of 5.7 billion yuan [18] - China Communications Construction Company signed new contracts worth 991.054 billion yuan in the first half of the year, a year-on-year increase of 3.14% [19] - Kehui Co. plans to use up to 70 million yuan of idle funds for cash management [22] Group 7 - Biological Shares' subsidiary received a clinical trial approval for a cat mRNA vaccine, the first of its kind in China [23] - Ruipu Biological received a clinical trial approval for a pig mRNA vaccine, which is the first economic animal mRNA vaccine in China [24] - Nanjing New Hundred's major assets were judicially frozen due to liquidity debt crisis faced by its controlling shareholder [27] Group 8 - Changshu Bank plans to merge three village banks and establish branches, pending shareholder approval [28] - Yong'an Pharmaceutical plans to reduce its holdings by up to 2.6323 million shares [29] - Zhujiang Co. received approval from the Shanghai Stock Exchange for a stock issuance to specific targets [31] Group 9 - Sanyangma's subsidiary signed a 120 million yuan procurement contract for sensor products [33] - Jintou City Development plans to purchase a villa property for approximately 7.1854 million yuan [35] - Yuanli Co. intends to acquire 100% of Tongsheng Co. through a combination of cash and stock issuance [36] Group 10 - Xin'an Century's controlling shareholder plans to reduce holdings by up to 2.22% of the company's shares [36] - Fute Technology plans to raise up to 528 million yuan through a private placement for various projects [36] - Helen Piano's actual controller is set to change, with stock resuming trading [37] Group 11 - Weiergao expects a net profit increase of 12.55% to 30.87% for the first half of the year [38] - Saiwei Microelectronics plans to transfer up to 18% of its shares through an agreement [40] - Yongli Co. intends to acquire a 22.75% stake in a subsidiary [42] Group 12 - ST Xiachuang plans to publicly transfer a 20% stake in Guangdong Yuweiji [43] - Dema Technology's shareholders plan to transfer 778.84 million shares through an inquiry [45] - Zhongshi Technology's shareholders plan to reduce holdings by up to 2.86% of the company's shares [46] Group 13 - Wufang Optoelectronics' controlling shareholder plans to reduce holdings by up to 0.93% of the company's shares [48] - Fusenmei's chairman has been detained, temporarily unable to fulfill his duties [49] - Reliable Co.'s shareholders plan to reduce holdings by a total of up to 2.63% of the company's shares [51] Group 14 - Gao Neng Environment plans to repurchase shares worth between 100 million and 150 million yuan [53]

福立旺精密机电（中国）股份有限公司 关于自愿披露 2025 年半年度业绩预告的公告 | 证券代码：688678 | 证券简称：福立旺 | 公告编号：2025-057 | | --- | --- | --- | | 转债代码：118043 | 转债简称：福立转债 | | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、本期业绩预告情况 （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 6 月 30 日。 （二）业绩预告情况 （1）经财务部门初步测算，福立旺精密机电（中国）股份有限公司（以下 简称"公司"）预计 2025 年半年度实现归属于母公司所有者的净利润为-1,700.00 万元左右，与上年同期（法定披露数据）相比，将减少 6,280.35 万元，同比减 少 137.12%左右。 （2）预计 2025 年半年度实现归属于母公司所有者的扣除非经常性损益的 净利润为-2,500.00 万元左右，与上年同期（法定披露数据）相比，将减少 6,009.58 万元，同比减少 171.23%左右。 （三）本次业绩预 ...

Group 1 - Datang Power achieved a total on-grid electricity of approximately 123.99 billion kWh for the first half of 2025, a year-on-year increase of 1.30%, with wind and solar power generation increasing by 31.27% and 36.35% respectively [1] - North Self Technology signed an equipment procurement contract with a total amount of 164 million yuan [1] - Jinchuan Co. reported a net profit of 1.38 billion yuan for the first half of 2025, a year-on-year decrease of 8.45%, with operating revenue of 6.96 billion yuan, an increase of 5.55% [1][2] Group 2 - Microchip Biotech expects a revenue of 407 million yuan for the first half of 2025, a year-on-year increase of 35%, and a net profit of approximately 30.06 million yuan, a year-on-year increase of 173% [3] - Zongheng Co. anticipates a revenue of 135 million yuan for the first half of 2025, a year-on-year increase of 61.72%, with a net loss of 34.68 million yuan, reducing losses by 18.34 million yuan compared to the previous year [5] - Tuojing Technology expects a revenue of 1.21 billion to 1.26 billion yuan for the second quarter of 2025, a year-on-year increase of 52% to 58%, with a net profit of 238 million to 247 million yuan, a year-on-year increase of 101% to 108% [7] Group 3 - Star Power reported a net profit of 73.42 million yuan for the first half of 2025, a year-on-year decrease of 13.44%, with total revenue of 1.52 billion yuan, an increase of 13.70% [8] - Xiamen Tungsten reported a net profit of 972 million yuan for the first half of 2025, a year-on-year decrease of 4.41%, with operating revenue of 19.18 billion yuan, an increase of 11.75% [9] - Yikang Pharmaceutical's subsidiary received approval for clinical trials of YKYY029 injection for hypertension [11] Group 4 - Mould Technology received a project designation for luxury car exterior parts, with an expected total sales of 2.044 billion yuan over a five-year lifecycle [13] - Jinzhik Technology won multiple projects from the State Grid and Southern Power Grid, with a total bid amount of 133 million yuan [14] - Changjiang Media plans to use up to 700 million yuan of idle funds to purchase financial products [16] Group 5 - Ningbo Gaofa plans to invest up to 20 million USD to establish a production base in Morocco [20] - Xuantai Pharmaceutical's subsidiary received EU GMP certification for solid dosage production lines [22] - Changhua Group received a project designation for key metal structural components from a domestic new energy vehicle company, with an expected total sales of 235 million yuan over a four-year lifecycle [23]

Meeting Overview - The shareholders' meeting of Fuliwang Precision Electromechanical (China) Co., Ltd. was held on July 16, 2025, with a total of 155 ordinary shareholders present, holding 113,585,222 voting rights, which accounts for 43.81% of the company's total voting rights [1][4]. Voting Results - All non-cumulative voting proposals were approved with a high majority, including: - 99.89% approval for the first proposal with 113,466,194 votes in favor [2]. - 99.91% approval for the second proposal with 113,483,794 votes in favor [1][2]. - 99.91% approval for the third proposal with 113,483,794 votes in favor [1][2]. - Cumulative voting results indicated that candidates for the fourth board of directors were elected with significant support, including independent directors [3][4]. Legal Compliance - The meeting's procedures, including the convening and voting processes, were confirmed to be in compliance with the Company Law and the company's articles of association, ensuring the legality and validity of the meeting [4].

Group 1 - The legal opinion letter was issued by Grandall Law Firm (Suzhou) regarding the second extraordinary general meeting of shareholders of Fuliwang Precision Electromechanical (China) Co., Ltd. held in 2025 [1][2] - The meeting was convened by the company's board of directors based on a resolution from the 28th meeting of the third board of directors held on June 30, 2025 [2][3] - The notice for the meeting was published on the Shanghai Stock Exchange website on July 1, 2025, detailing the time, location, convenor, agenda, and registration methods [2][3] Group 2 - The meeting utilized a combination of on-site and online voting, with the on-site meeting held on July 16, 2025, at 14:00 [3][4] - A total of 155 participants attended the meeting, representing 113,585,222 shares, which accounted for 43.8097% of the total voting shares [5][6] - The qualifications of the convenor and attendees were verified to be in compliance with the Company Law and the company's articles of association [4][5] Group 3 - The voting procedures followed the requirements outlined in the meeting notice, with results collected from both on-site and online votes [6][12] - The resolutions passed during the meeting included significant support, with votes in favor reaching as high as 99.9107% for various proposals [6][10] - The voting results indicated that the resolutions met the necessary thresholds for both special and ordinary resolutions as per legal requirements [11][12]

Group 1 - The company will initiate the board of directors' re-election process on June 30, 2025, with a second extraordinary shareholders' meeting scheduled for July 16, 2025, to approve relevant proposals [1] - The fourth board of directors will consist of seven members, including one employee director elected by the employee representative assembly [1] - Chen Xiuping has been elected as the employee director and will serve alongside the other six directors elected at the extraordinary shareholders' meeting [1] Group 2 - Chen Xiuping's career includes roles as Deputy Manager of the Information Department from January 2018 to December 2019, and currently as Manager of the Information Department since January 2020 [3] - Chen Xiuping has no shareholding in the company and has no relationships with major shareholders or other board members [3] - Chen Xiuping meets the qualifications as per the Company Law of the People's Republic of China and the company's articles of association [3]

Core Viewpoint - The company intends to conduct foreign exchange hedging activities to mitigate risks associated with currency fluctuations, with a maximum amount of $30 million or equivalent foreign currency for a period of 12 months [1][2][3] Summary by Sections 1. Necessity of Conducting Foreign Exchange Hedging - The company primarily conducts export business in foreign currencies such as USD and EUR, making it susceptible to exchange rate fluctuations that could negatively impact its financial performance. The hedging activities aim to enhance the efficiency of foreign currency usage and reduce financial costs [2][3] 2. Overview of Proposed Hedging Activities - The hedging activities will be limited to currencies used in the company's operations, specifically USD and EUR. The types of hedging products include but are not limited to forward foreign exchange contracts, foreign exchange swaps, and options [2][3] 3. Business Scale and Funding Source - The maximum amount for the hedging activities is set at $30 million or equivalent foreign currency, with the ability to roll over within this limit for a duration of 12 months. The funding will come from the company's own funds and will not involve raised capital [3] 4. Authorization and Duration - The board of directors has authorized the general manager to approve daily hedging plans and sign relevant contracts within the authorized limit. The finance department will manage the execution of these activities, with the authorization valid for 12 months from the board's approval [3] 5. Trading Counterparties - The company will engage with banks and financial institutions that have the necessary qualifications for conducting foreign exchange hedging activities, as approved by relevant government authorities [3] 6. Accounting Treatment - The company will adhere to the accounting standards set by the Ministry of Finance of the People's Republic of China regarding financial instruments and hedging accounting, with final accounting treatment confirmed by annual audits [3] 7. Risk Analysis - The company acknowledges potential risks associated with exchange rate and interest rate fluctuations, internal control weaknesses, counterparty defaults, customer payment delays, and legal risks due to regulatory changes [4][5] 8. Risk Control Measures - The company has established a management system for foreign exchange hedging that outlines limits, product types, approval authority, and internal review processes. The finance department will oversee the management of market risks, while the internal audit department will monitor compliance with risk management policies [5] 9. Review Procedures - The board of directors approved the hedging proposal during a meeting on July 16, 2025, confirming that the activities are necessary for mitigating exchange rate risks and enhancing financial stability. The proposal does not require shareholder approval [6][7] 10. Sponsor's Opinion - The sponsor, CITIC Securities, has verified that the company has followed necessary legal procedures for the hedging activities and has established an internal control system for managing these operations [7]

Core Viewpoint - The announcement details the completion of the board of directors' re-election and the appointment of senior management personnel at Freewon Precision Electromechanical (China) Co., Ltd, marking a significant governance change for the company [1]. Group 1: Board Composition - The fourth board of directors consists of three non-independent directors, three independent directors, and one employee representative director, with a term of three years starting from the approval date of the shareholders' meeting [1][2]. - Xu Huijun was elected as the chairman of the fourth board of directors, and various specialized committees were formed, including the Strategy Committee, Audit Committee, Nomination Committee, and Compensation and Assessment Committee [2]. Group 2: Senior Management Appointments - Xu Huijun was appointed as the general manager, Xu Yazhu as the executive deputy general manager, He Yuliang and Luo Hongzhen as deputy general managers, Chen Jun as the financial director, and You Dongcha as the board secretary, with their terms lasting until the end of the fourth board's term [4][5]. - All appointed senior management personnel meet the qualifications required by relevant laws and regulations, ensuring compliance with the Company Law and the Shanghai Stock Exchange's listing rules [5]. Group 3: Securities Affairs Representative - Liu Jinfeng was appointed as the securities affairs representative, assisting the board secretary, with her term also lasting until the end of the fourth board's term [5][12]. - Liu Jinfeng holds the necessary qualifications and experience for the role, having previously served as a financial and securities affairs specialist within the company [12].

关于福立旺精密机电（中国）股份有限公司 开展外汇套期保值业务的核查意见 中信证券股份有限公司 中信证券股份有限公司（以下简称"中信证券"或"保荐人"）作为福立旺 精密机电（中国）股份有限公司（以下简称"福立旺"或"公司"）向不特定对 象发行可转换公司债券并在科创板上市项目的保荐人，根据《证券发行上市保荐 业务管理办法》《上海证券交易所科创板股票上市规则》《上海证券交易所上市 公司自律监管指引第 1 号——规范运作》等有关规定，对公司本次开展外汇套期 保值业务进行了核查，具体情况如下： 一、开展外汇套期保值业务的必要性 公司出口业务主要采用美元、欧元等外币进行结算，因此当汇率出现较大波 动时，汇兑损益将对公司的经营业绩造成一定影响。为有效规避外汇市场的风险， 防范汇率波动对公司经营业绩造成不利影响，提高外汇资金使用效率，合理降低 财务费用，公司拟与银行开展外汇套期保值业务。公司的外汇套期保值业务以正 常生产经营为基础，以规避和防范汇率风险为目的，不进行单纯以盈利为目的的 投机和套利交易。 二、拟开展的套期保值业务概述 （一）主要涉及币种及业务品种 公司拟开展的外汇套期保值业务资金额度不超过 3,000.00 万 ...

二〇二五年七月十七日 | 证券代码：688678 | 证券简称：福立旺 | 公告编号：2025-054 | | --- | --- | --- | | 转债代码：118043 | 转债简称：福立转债 | | 福立旺精密机电（中国）股份有限公司 关于选举职工代表董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 福立旺精密机电（中国）股份有限公司（以下简称"公司"）第三届董事会 任期即将届满，公司于 2025 年 6 月 30 日启动董事会换届工作，于 2025 年 7 月 16 日召开 2025 年第二次临时股东大会审议通过相关议案，根据《中华人民 共和国公司法》《福立旺精密机电（中国）股份有限公司章程》等相关规定，公 司第四届董事会由七名董事组成，其中一名为职工董事，由公司职工代表大会选 举产生。 公司于 2025 年 7 月 16 日召开职工代表大会，选举陈秀平女士为公司第四 届董事会职工董事，陈秀平女士将与公司 2025 年第二次临时股东大会选举产生 的其他 6 名董事共同组成公司第四届董事会，任期与第四届董 ...